Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 20-year lows after its shock warning this week.
Bayer's Icafolin will be its first new mode of action herbicide in some 30 years when it launches in 2028